Latest Landauer Stories

GLENWOOD, Ill., July 23 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR), will release financial results for the fiscal third quarter of 2009 pre-market on Tuesday, August 4, 2009. The company will host a conference call for investors on Tuesday, August 4, 2009, at 2:00 p.m. Eastern Time. Investors may access the live call by dialing 877-941-7133 (within the United States and Canada), or 480-629-9786 (international callers), and referencing the conference ID #4123060, or by visiting the...

GLENWOOD, Ill., April 23 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR), will release financial results for the fiscal second quarter of 2009 pre-market on Tuesday, May 5, 2009. The company will host a conference call for investors on Tuesday, May 5, 2009, at 2:00 p.m. Eastern Time. Investors may access the live call by dialing 877-941-1469 (within the United States and Canada), or 480-629-9675 (international callers), and referencing the conference ID #4064265, or by visiting the...

GLENWOOD, Ill., Jan. 26 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR), will release financial results for the fiscal first quarter of 2009 pre-market on Tuesday, February 3, 2009. The company will host a conference call for investors on Tuesday, February 3, 2009, at 2:00 p.m. Eastern Time. Investors may access the live call by dialing 800-240-2430 (within the United States and Canada), or 303-262-2053 (international callers), or by visiting the "Investors" page on the...

Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation monitoring, today announced that noted medical physicist, Paul A. Jursinic, Ph.D., will be presenting at ASTRO his findings on the superiority of Landauer's Optically Stimulated Luminescence Dosimetry (OSLD) for clinical dosimetric measurements. Dr. Jursinic is renowned among health physicists for his rigorous focus on QA, and he has investigated a wide range of technologies for efficiency and precision in...